Skip to main content
. 2022 Feb 22;2022:6580030. doi: 10.1155/2022/6580030

Table 2.

The comparison of the serum levels between the two groups before and after treatment (x¯±s).

Group Number of cases GDNF (pg.mL−1) NSE (μg. L−1) IL-1β (μg. L−1) MBP (μg. L−1)
Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment
The control group 73 354.9 ± 38.6 522.5 ± 57.3 33.4 ± 4.6 22.7 ± 3.6 51.6 ± 6.5 26.3 ± 4.2 2.8 ± 0.5 2.4 ± 0.4
The research group 75 355.2 ± 38.5 592.33 ± 62.5 33.2 ± 4.5 14.3 ± 2.3 51.8 ± 6.7 18.3 ± 2.6 2.8 ± 0.6 2.0 ± 0.3
T / 1.527 17.628 0.158 15.034 1.985 16.5428 0.854 14.936
P / >0.05 <0.05 >0.05 <0.05 >0.05 <0.05 >0.05 <0.05